Randomized, Double-blind, Placebo-controlled Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne

NCT02322866 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1034

Enrollment

INDUSTRY

Sponsor class

Conditions

Acne Vulgaris

Interventions

DRUG: Sarecycline
DRUG: Placebo

Sponsor

Almirall, S.A.

Collaborators

[object Object]